Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Angle, Abbott Ink Deal for Use of FISH With Harvested CTCs

Angle, Abbott Ink Deal for Use of FISH With Harvested CTCs

Feb 06, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Angle said today that Abbott will supply PathVysion HER-2 DNA FISH kits for a study aimed at investigating analysis of circulating tumor cells. 

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. BARDA Exercises $10.5M Option on T2 Bio Contract

  2. PerkinElmer Newborn Screening Assay Receives CE-IVD Mark

  3. Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production

  4. Access Genetics Nabs Amended FDA Emergency Use Authorization for Oral Rinse SARS-CoV-2 PCR Test

  5. Israeli Startup LessTests Uses Single-Step Pooling Software to Multiply COVID-19 Testing Capacity

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.